ETF Overlap Tool
Enter up to six ETFs to see how much of each is the same securities. Overlap by weight is the sum, over every holding two funds share, of the smaller of the two weights: 100% means identical portfolios, 0% means nothing in common.
Overlap by weight
40 holdings in all 2 funds| Fund | KURE | MCHI | Positions | Holdings |
|---|---|---|---|---|
| KUREKraneShares MSCI All China Health Care Index ETF | — | 5% 40 shared |
46 | as of Jun 30, 2026SEC filing |
| MCHIiShares MSCI China ETF | 5% 40 shared | — | 577 | as of Oct 8, 2026issuer data |
Each cell: overlap by weight, and how many positions the two funds share. Equity, preferred and fund holdings are compared; cash and derivatives are not.
Held by both funds
5.3% common weight| Holding | KURE | MCHI | Smallest |
|---|---|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | 7.51% | 1.02% | 1.02% |
| INNOVENT BIOLOGICS, INC. | 8.80% | 0.71% | 0.71% |
| WuXi AppTec Co., Ltd. | 3.35% | 0.44% | 0.44% |
| CSPC PHARMACEUTICAL GROUP LIMITED | 3.68% | 0.40% | 0.40% |
| Akeso Inc | 3.72% | 0.37% | 0.37% |
| SINO BIOPHARMACEUTICAL LIMITED | 3.38% | 0.29% | 0.29% |
| Genscript Biotech Corp | 1.11% | 0.26% | 0.26% |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | 2.85% | 0.21% | 0.21% |
| WuXi XDC Cayman Inc | 1.35% | 0.17% | 0.17% |
| 3SBio Inc. | 2.49% | 0.15% | 0.15% |
| WuXi AppTec Co., Ltd. | 5.79% | 0.15% | 0.15% |
| Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | 1.85% | 0.15% | 0.15% |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.59% | 0.11% | 0.11% |
| SINOPHARM GROUP CO. LTD. | 1.67% | 0.11% | 0.11% |
| XtalPi Holdings Limited | 1.00% | 0.11% | 0.11% |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.28% | 0.07% | 0.07% |
| RemeGen Co Ltd | 1.05% | 0.07% | 0.07% |
| LEGN | 1.28% | 0.06% | 0.06% |
| Shanghai United Imaging Healthcare Co., Ltd. | 2.27% | 0.03% | 0.03% |
| YUNNAN BAIYAO GROUP CO., LTD | 2.31% | 0.03% | 0.03% |
| ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | 1.81% | 0.03% | 0.03% |
| Aier Eye Hospital Group Co., Ltd. | 2.10% | 0.03% | 0.03% |
| Pharmaron Beijing Co., Ltd. | 1.15% | 0.03% | 0.03% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 1.61% | 0.02% | 0.02% |
| Sichuan Biokin Pharmaceutical Co Ltd | 1.97% | 0.02% | 0.02% |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.30% | 0.02% | 0.02% |
| CSPC Innovation Pharmaceutical Co Ltd | 0.74% | 0.02% | 0.02% |
| Haisco Pharmaceutical Group Co., Ltd. | 1.53% | 0.02% | 0.02% |
| HUADONG MEDICINE CO., LTD | 1.36% | 0.02% | 0.02% |
| RemeGen Co Ltd | 1.26% | 0.02% | 0.02% |
| Shanghai Pharmaceuticals Holding Co., Ltd. | 1.17% | 0.02% | 0.02% |
| Shanghai Allist Pharmaceuticals Co Ltd | 1.34% | 0.02% | 0.02% |
| APT Medical Inc | 0.70% | 0.01% | 0.01% |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1.03% | 0.01% | 0.01% |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | 0.97% | 0.01% | 0.01% |
| Shenzhen New Industries Biomedical Engineering Co Ltd | 0.90% | 0.01% | 0.01% |
| BEIJING TONG REN TANG CO., LTD | 0.86% | 0.01% | 0.01% |
| Shanghai RAAS Blood Products Co., Ltd. | 0.79% | 0.01% | 0.01% |
| Imeik Technology Development Co Ltd | 0.72% | 0.01% | 0.01% |
| Hangzhou Tigermed Consulting Co., Ltd | 0.46% | 0.01% | 0.01% |
Reading overlap
Two funds with 80% overlap move together and holding both mostly doubles one exposure and both fees. Low overlap is not the same as diversification: two funds can share no holdings and still be driven by the same factor. To see what a whole portfolio owns, use the portfolio x-ray.
Holdings come from each issuer's daily file where we have one and otherwise from the fund's latest SEC filing, so the two sides of a comparison can be from different dates. The table shows each fund's date.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.